Evidence map›Paper›PMID 39148541›Full record

ArticleFrontiers in pharmacology2024

Pharmacokinetics and tissue distribution of LN002, a new compound alternative oxidase inhibitor against

Minglang Ma, Yongxiang Zhang, Yanjun Fang, Yixing Lu, Huiguo Huang, Zhenling Zeng, Dongping Zeng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Minglang Ma *Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety. Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal. Original Bacteria, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
Yongxiang Zhang *Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety. Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal. Original Bacteria, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
Yanjun FangGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety. Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal. Original Bacteria, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
Yixing LuGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety. Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal. Original Bacteria, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
Huiguo HuangGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety. Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal. Original Bacteria, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
Zhenling ZengGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety. Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal. Original Bacteria, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
Dongping ZengGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety. Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal. Original Bacteria, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptosporidiosis is considered a crucial zoonotic disease caused by widely distributing parasitic protozoa called

Indexed as

alternative oxidase inhibitorscryptosporidiosisHPLCpharmacokinetics, tissue distributionrat

Identifiers

PMID39148541
PMCPMC11325084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.